Dr. Mohammad Kamgar, MD

Dr. Kamgar practices at DaVita Century City Dialysis in Los Angeles, California.

Dr. Kamgar's NPI, 1275788440, was assigned on December 1, 2008. Dr. Kamgar graduated from Tehran University of Medical Sciences School of Medicine in 2001. Dr. Kamgar holds California license A101658.

Dr. Kamgar's primary practice is DaVita Century City Dialysis, at 10630 Santa Monica Boulevard, Los Angeles, CA 90025 in Los Angeles County. The practice phone is (310) 954-2700.

Dr. Kamgar's primary practice is DaVita Century City Dialysis in Los Angeles, California. Dr. Kamgar is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Kamgar to 1 more hospital, 1 dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kamgar practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kamgar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kamgar is board certified in nephrology by the American Board of Internal Medicine. Dr. Kamgar is licensed in California.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney disease and parathyroid gland disorder among the conditions Dr. Kamgar treats.

CMS data shows 2,167 Medicare services from Dr. Kamgar across 7 procedure codes in 2024, for 497 Medicare patients. Medicare paid $194,589 for them.

CMS counts 497 Medicare patients who saw Dr. Kamgar in 2024. The largest group is 65 to 74, with 188 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 43% are also on Medicaid. Their average risk score is 4.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kamgar's median patient age at 63, with 42% women.

In 2024, Dr. Kamgar wrote 896 Medicare Part D claims for 153 patients. 83% of them were for generic drugs. CMS names the drug for 669 of them, across 27 drugs with 11 or more claims each, at $101,015 in total drug cost. In 2023, CMS named 545 claims across 24 drugs.

Dr. Kamgar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kamgar as offering telehealth.

Dmand AI links 5 papers to Dr. Kamgar, published from 2015 to 2025. 2025 was the busiest year, with 2. Dr. Kamgar's most frequent co-authors are Ramy Magdy Hanna, MD, Kamyar Zadeh Kalantar-Zadeh, MD and Niloofar Nobakht, MD.

CMS Open Payments shows 748 general payments to Dr. Kamgar from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 58% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $213,674.

Dr. Kamgar graduated from Tehran University of Medical Sciences School of Medicine in 2001.

Dr. Kamgar is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.